Manish Adhikari1, Jesús Delgado-Calle2,3. 1. Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA. 2. Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA. jdelgadocalle@uams.edu. 3. Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA. jdelgadocalle@uams.edu.
Abstract
PURPOSE OF REVIEW: The goal of this manuscript is to review the current knowledge on the role of osteocytes in cancer in the bone, discuss the potential of osteocytes as a therapeutic target, and propose future research needed to understand the crosstalk between cancer cells and osteocytes in the tumor niche. RECENT FINDINGS: Numerous studies have established that cancer cells manipulate osteocytes to facilitate invasion and tumor progression in bone. Moreover, cancer cells dysregulate osteocyte function to disrupt physiological bone remodeling, leading to the development of bone disease. Targeting osteocytes and their derived factors has proven to effectively interfere with the progression of cancer in the bone and the associated bone disease. Osteocytes communicate with cancer cells and are also part of the vicious cycle of cancer in the bone. Additional studies investigating the role of osteocytes on metastases to the bone and the development of drug resistance are needed.
PURPOSE OF REVIEW: The goal of this manuscript is to review the current knowledge on the role of osteocytes in cancer in the bone, discuss the potential of osteocytes as a therapeutic target, and propose future research needed to understand the crosstalk between cancer cells and osteocytes in the tumor niche. RECENT FINDINGS: Numerous studies have established that cancer cells manipulate osteocytes to facilitate invasion and tumor progression in bone. Moreover, cancer cells dysregulate osteocyte function to disrupt physiological bone remodeling, leading to the development of bone disease. Targeting osteocytes and their derived factors has proven to effectively interfere with the progression of cancer in the bone and the associated bone disease. Osteocytes communicate with cancer cells and are also part of the vicious cycle of cancer in the bone. Additional studies investigating the role of osteocytes on metastases to the bone and the development of drug resistance are needed.
Authors: George H Searfoss; William H Jordan; David O Calligaro; Elizabeth J Galbreath; Linda M Schirtzinger; Brian R Berridge; Hong Gao; Marnie A Higgins; Patrick C May; Timothy P Ryan Journal: J Biol Chem Date: 2003-08-29 Impact factor: 5.157
Authors: Timothy J Myers; Lara Longobardi; Helen Willcockson; Joseph D Temple; Lidia Tagliafierro; Ping Ye; Tieshi Li; Alessandra Esposito; Billie M Moats-Staats; Anna Spagnoli Journal: J Bone Miner Res Date: 2015-06-15 Impact factor: 6.741
Authors: W G Jiang; A J Sanders; M Katoh; H Ungefroren; F Gieseler; M Prince; S K Thompson; M Zollo; D Spano; P Dhawan; D Sliva; P R Subbarayan; M Sarkar; K Honoki; H Fujii; A G Georgakilas; A Amedei; E Niccolai; A Amin; S S Ashraf; L Ye; W G Helferich; X Yang; C S Boosani; G Guha; M R Ciriolo; K Aquilano; S Chen; A S Azmi; W N Keith; A Bilsland; D Bhakta; D Halicka; S Nowsheen; F Pantano; D Santini Journal: Semin Cancer Biol Date: 2015-04-10 Impact factor: 15.707
Authors: Constantine S Mitsiades; Enrique M Ocio; Atanasio Pandiella; Patricia Maiso; Consuelo Gajate; Mercedes Garayoa; David Vilanova; Juan Carlos Montero; Nicholas Mitsiades; Ciaran J McMullan; Nikhil C Munshi; Teru Hideshima; Dharminder Chauhan; Pablo Aviles; Gabriel Otero; Glynn Faircloth; M Victoria Mateos; Paul G Richardson; Faustino Mollinedo; Jesus F San-Miguel; Kenneth C Anderson Journal: Cancer Res Date: 2008-07-01 Impact factor: 12.701